Although both TGF-β signaling and CAFs promote EMT in various cancers [5, 14], it is unclear which of the TGF-β family members (TGF-β1, TGF-β2, and TGF-β3) are responsible in BLCA. This evidence concerns the gene TGFB2 and bladder transitional cell carcinoma.